Amoura, Zahir
Sorbonne Université · Pitié-Salpêtrière Hospital · Centre d'Immunologie et des Maladies Infectieuses
11 papers on CoChatORCID 0000-0003-0292-9043
Most cited papers
- Verified
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science
interferon and immune responsesSARS-CoV-2 and COVID-19 Research
Cited by 2,662
- Verified
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity
T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis
Cited by 2,291
- Verified
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science
interferon and immune responsesSARS-CoV-2 and COVID-19 Research
Cited by 2,229
- Verified
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics
Cholesterol and Lipid MetabolismDrug Transport and Resistance Mechanisms
Cited by 1,433
- Verified
EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases
Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms
Cited by 1,318
- Verified
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claër, L., Quentric, P., Fadlallah, J., Devilliers, H., Ghillani, P., et al. (2021) · Science Translational Medicine
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,037
- Verified
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases
Systemic Lupus Erythematosus ResearchVasculitis and related conditions
Cited by 974
- Verified
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Barbhaiya, M., Zuily, S., Naden, R., Hendry, A., Manneville, F., Amigo, M.-C., Amoura, Z., Andrade, D., Andreoli, L., Artim-Esen, B., et al. (2023) · Annals of the Rheumatic Diseases
Systemic Lupus Erythematosus ResearchVasculitis and related conditions
Cited by 493
- Verified
Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis
Arnaud, L., Mathian, A., Ruffatti, A., Erkan, D., Tektonidou, M., Cervera, R., Forastiero, R., Pengo, V., Lambert, M., Martinez-Zamora, M. A., et al. (2014) · Autoimmunity Reviews
Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms
Cited by 215
- Verified
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
Arnaud, L., Mathian, A., Devilliers, H., Ruffatti, A., Tektonidou, M., Forastiero, R., Pengo, V., Lambert, M., Lefevre, G., Martinez-Zamora, M. A., et al. (2015) · Autoimmunity Reviews
Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms
Cited by 146
- Verified
Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients
Jamilloux, Y., Cohen-Aubart, F., Chapelon-Abric, C., Maucort-Boulch, D., Marquet, A., Pérard, L., Bouillet, L., Deroux, A., Abad, S., Bielefeld, P., et al. (2017) · Seminars in Arthritis and Rheumatism
Sarcoidosis and Beryllium Toxicity ResearchHistiocytic Disorders and Treatments
Cited by 98
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free